Czechia SUKL · August 06, 2026

Healthcare Professional Communication: Desogestrel and etonogestrel – meningoma risk and risk minimisation measures

Original title: Informační dopis pro zdravotnické pracovníky – desogestrel a etonogestrel

Direct healthcare professional communication on meningoma risk associated with desogestrel and etonogestrel-containing medicinal products and measures to minimise this risk.

Low obligation Product class Pharmaceuticals Czech Republic Pharmacovigilance

Informační dopis pro zdravotnické pracovníky – Léčivé přípravky obsahující desogestrel a etonogestrel: Riziko meningiomu a opatření k minimalizaci tohoto rizika

Read the official source ↗

Published by Czechia SUKL. HealthSignal links to the original document; the summary above is extracted from the source text.